Results 11 to 20 of about 18,199 (141)

A Rare Multifocal Pattern of Type 2 Autoimmune Pancreatitis with Negative IgG4: A Potential Diagnostic Pitfall That May Mimic Multifocal Pancreatic Adenocarcinoma [PDF]

Case Reports in Gastroenterology, 2018
Autoimmune pancreatitis (AIP) is an increasingly recognized form of acute pancreatitis characterized by obstructive jaundice with a rapid and dramatic treatment response to steroid therapy.
Partha Hota, Tejas Patel, Xiaofeng Zhao, Nirag Jhala, Omar Agosto   +4 more
doaj   +2 more sources

A Case of Type 2 Autoimmune Pancreatitis Suggesting Two Potential Disease Activity Markers [PDF]

Gastro Hep Advances
Autoimmune pancreatitis (AIP) is divided into 2 main subtypes: type 1 AIP (AIP-1) and type 2 AIP (AIP-2). This report describes a young woman diagnosed with AIP-2 using endoscopic ultrasound–guided tissue acquisition.
Kazuki Natsui, Seiichi Yoshikawa, Ayano Kagata, Yusuke Horibata, Hiroyuki Usuda, Manabu Takeuchi, Shuji Terai   +6 more
doaj   +2 more sources

Autoimmune pancreatitis: What we know so far

JGH Open, 2022
Autoimmune pancreatitis (AIP) is a rare, often‐missed disease that involves inflammation of the pancreas and strictures of the pancreatic duct. Its prevalence and incidence in the United States remain scarce.
Muaaz Masood
doaj   +1 more source

Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double‐blind, placebo‐controlled clinical trial

Hepatology, EarlyView., 2022
NRPT 1X reduces ALT and ceramide 14:0 in 65% of subjects as compared to only 28% in the placebo group. Abstract Background and Aims The prevalence of NAFLD is increasing globally and on a path to becoming the most frequent cause of chronic liver disease. Strategies for the prevention and treatment of NAFLD are urgently needed.
Ryan W. Dellinger, Holly E. Holmes, Tina Hu‐Seliger, Rodney W. Butt, Stephen A. Harrison, Dariush Mozaffarian, Oliver Chen, Leonard Guarente   +7 more
wiley   +1 more source

Autoimmune pancreatitis type 1 and type 2: A report of two cases [PDF]

Vojnosanitetski Pregled, 2017
Introduction. Autoimmune pancreatitis is a disease associated with autoimmune mechanisms, clinically manifested mostly as obstructive icterus with or with no entire or partial enlargement of the pancreas, histological lymphoplas-mocytic infiltration ...
Brčerević Irina, Doder Radoje, Perišić Nenad, Petrović Stanko, Jović Jasna, Hristović Dejan, Đorđević Zoran, Tasić-Radić Olga   +7 more
doaj   +1 more source

Autoimmune pancreatitis type 2: Mimicking pancreatic cancer

Formosan Journal of Surgery, 2020
Autoimmune pancreatitis (AIP) is a rare disease, which comprises two distinct forms of steroid response chronic pancreatitis. AIP type 2 with no association to IgG level and more confined to the pancreas makes it hard to differentiate with pancreatic ...
Tien-An Lin, Tse-Ching Chen, Jeng-Hwei Tseng, Ta-Sen Yeh   +3 more
doaj   +1 more source

Autoimmune Pancreatitis Type 2: Disentangling a Rare Entity of Obstructive Jaundice [PDF]

Journal of Clinical and Diagnostic Research, 2018
Autoimmune Pancreatitis (AIP) can be a clinical challenge in diagnosis and treatment. It often presents with painless obstructive jaundice, which mimics pancreatic cancer. Surgical treatment is not recommended in the management of AIP. However, there are
Dimosthenis Chrysikos, Konstantinos Toutouzas, Constantine G Zografos, Olga Bellou   +3 more
doaj   +1 more source

New-onset Type 1 Diabetes Mellitus with Diabetic Ketoacidosis and Pancreatitis in a Patient with COVID-19

Scientific African, 2021
Coronavirus Disease 2019 (COVID-19) had struck the world with health and economic catastrophes and recently with unusual autoimmune presentations, including new-onset Type 1 Diabetes.Herein we present a 17-year-old male patient who presented to the ...
Mostafa Alfishawy, Mahmoud Nassar, Mahmoud Mohamed, Moataz Fatthy, Riem M. Elmessiery   +4 more
doaj   +1 more source

Autoimmune Pancreatitis Type 2: Case Report

Journal of Investigative Medicine High Impact Case Reports, 2017
A middle-aged man presents with acute pancreatitis of unknown etiology and is found to have a presentation consistent with the diagnosis of type 2 autoimmune pancreatitis (AIP).
Chidinma Onweni MD, Harika Balagoni MD, Jennifer M. Treece MD, MBA, Emmanuel Addo Yobo MD, Archi Patel MD, Jennifer Phemister MD, Manoj Srinath MD, Mark F. Young MD   +7 more
doaj   +1 more source

Pancreatic adverse events in patients treated with immune checkpoint inhibitors

JGH Open, 2023
Background and Aim The inhibition of cytotoxic T‐lymphocyte associated antigen‐4 (CTLA‐4) and programmed cell death‐1 (PD‐1) has been a target for multiple drugs to enhance the T‐cell antitumor activity. However, these immune checkpoint inhibitors (ICIs)
Caroline Hana, Tauseef Rehman, Kyeeun Park, Carlos Carracedo Uribe, Pyi Phyo Aung, Brian Hunis, Matthew Salzberg, Jennifer Zikria, Atif Hussein   +8 more
doaj   +1 more source